<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
<channel>
<title>4 Medizinische Fakultät</title>
<link>http://hdl.handle.net/10900/33644</link>
<description/>
<pubDate>Tue, 27 Oct 2026 09:08:47 GMT</pubDate>
<dc:date>2026-10-27T09:08:47Z</dc:date>
<item>
<title>Polar Fourier transform in practice: its efficiency and characteristics in reconstructing radially acquired MRI images</title>
<link>http://hdl.handle.net/10900/184979</link>
<description>Polar Fourier transform in practice: its efficiency and characteristics in reconstructing radially acquired MRI images
Aghaeifar, Ali; Scheffler, Klaus
</description>
<pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/10900/184979</guid>
<dc:date>2026-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>Integrated in vivo combinatorial functional genomics and spatial transcriptomics of tumours to decode genotype-to-phenotype relationships</title>
<link>http://hdl.handle.net/10900/184977</link>
<description>Integrated in vivo combinatorial functional genomics and spatial transcriptomics of tumours to decode genotype-to-phenotype relationships
Gerstung, Moritz
</description>
<pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/10900/184977</guid>
<dc:date>2026-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>EnsembleAge: enhancing epigenetic age assessment with a multi-clock framework</title>
<link>http://hdl.handle.net/10900/184976</link>
<description>EnsembleAge: enhancing epigenetic age assessment with a multi-clock framework
Jucker, Mathias; Bergmann, Carina
</description>
<pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/10900/184976</guid>
<dc:date>2026-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>Treatment persistence, lipid lowering, and 3-year clinical outcomes in patients at very high cardiovascular risk on PCSK9 monoclonal antibodies</title>
<link>http://hdl.handle.net/10900/184974</link>
<description>Treatment persistence, lipid lowering, and 3-year clinical outcomes in patients at very high cardiovascular risk on PCSK9 monoclonal antibodies
Birkenfeld, Andreas L.
</description>
<pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/10900/184974</guid>
<dc:date>2026-01-01T00:00:00Z</dc:date>
</item>
</channel>
</rss>
